Fig. 1From: Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood–brain barrier modelSchematic of the formation of Afa-loaded and peptide-modified LPN. Peptides include FD7 or CCD peptideBack to article page